INDEMNIFICATION AGREEMENTIndemnification Agreement • August 31st, 2010 • BG Medicine, Inc. • Services-medical laboratories • Delaware
THIS INDEMNIFICATION AGREEMENT (this “Agreement”) is made and entered into this day of , 20 , by and between BG MEDICINE, INC., a Delaware corporation (the “Corporation”), and (“Agent”).
RESTRICTED STOCK AGREEMENT BG MEDICINE, INC.Restricted Stock Agreement • August 31st, 2010 • BG Medicine, Inc. • Services-medical laboratories • Delaware
AGREEMENT made as of the day of , 20 (the “Grant Date”), between BG Medicine, Inc. (the “Company”), a Delaware corporation, and (the “Participant”).
FIRST LOAN MODIFICATION AGREEMENTLoan Modification Agreement • August 31st, 2010 • BG Medicine, Inc. • Services-medical laboratories • California
This First Loan Modification Agreement (this “Loan Modification Agreement”) is entered into as of March 28, 2008, by and between SILICON VALLEY BANK, a California corporation, with its principal place of business at 3003 Tasman Drive, Santa Clara, California 95054 and with a loan production office located at One Newton Executive Park, Suite 200, 2221 Washington Street, Newton, Massachusetts 02462 (“Bank”) and BG MEDICINE, INC., a Delaware corporation with its chief executive office located at 610 Lincoln Street, Waltham, Massachusetts 02451.
CONFIDENTIAL GALECTIN-3 LICENSE AND DISTRIBUTION AGREEMENTLicense and Distribution Agreement • August 31st, 2010 • BG Medicine, Inc. • Services-medical laboratories • Delaware
This GALECTIN-3 LICENSE AND DISTRIBUTION AGREEMENT (this “Agreement”), entered into as of November 11, 2009 (the “Effective Date”), by and between Abbott Laboratories, a corporation of the state of Illinois, having its principal place of business at 100 Abbott Park Road, Abbott Park, IL 60064-3500 (“Abbott”) and BG Medicine, Inc., a corporation of the state of Delaware, having its principal place of business at 610 Lincoln Street North Waltham, MA 02451 (“BGM”).
LICENSE AND SUPPLY AGREEMENTLicense and Supply Agreement • August 31st, 2010 • BG Medicine, Inc. • Services-medical laboratories • North Carolina
This License and Supply Agreement (“Agreement”) is effective as of the 13th day of May, 2010 (the “Effective Date”), between BG Medicine, Inc., a Delaware corporation with offices located at 610N Lincoln Street, Waltham, MA 02451 (“BGM”), and Laboratory Corporation of America Holdings, a Delaware corporation with offices located at 531 South Spring Street, Burlington, NC 27215 (“LabCorp”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 31st, 2010 • BG Medicine, Inc. • Services-medical laboratories • Delaware
THIS SECURITIES PURCHASE AGREEMENT, (the “Purchase Agreement”) dated as of March 30, 2010 (the “Effective Date”), is by and among BG Medicine, Inc., a Delaware Corporation (the “Company”), and the persons or entities identified on Schedule A attached hereto (which persons or entities, with any of their successors or assignees, are hereinafter referred to individually as a “Purchaser” and collectively, the “Purchasers”).
THIRD LOAN MODIFICATION AGREEMENTLoan Modification Agreement • August 31st, 2010 • BG Medicine, Inc. • Services-medical laboratories
This Third Loan Modification Agreement (this “Loan Modification Agreement”) is entered into as of November 26, 2008, by and between SILICON VALLEY BANK, a California corporation, with its principal place of business at 3003 Tasman Drive, Santa Clara, California 95054 and with a loan production office located at One Newton Executive Park, Suite 200, 2221 Washington Street, Newton, Massachusetts 02462 (“Bank”) and BG MEDICINE, INC., a Delaware corporation with its chief executive office located at 610 Lincoln Street, Waltham, Massachusetts 02451.
